echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Radiology: Application of Artificial Intelligence in DCE MRI Pharmacokinetic Parameters of Astrocytoma

    Radiology: Application of Artificial Intelligence in DCE MRI Pharmacokinetic Parameters of Astrocytoma

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dynamic-enhanced (DCE) MRI can be used to grade astrocytoma as well as to identify pseudo-progressive tumors
    .


    More specifically, pharmacokinetic (PK) parameters derived from DCE MRI, such as volume transfer constant (K trans ), extravascular extracellular space fraction or extravascular extracellular space volume per unit tissue (V e ), and plasma Interstitial volume fraction (V p ) can be used to evaluate tumor angiogenesis (V p ) and microcirculation permeability (K trans and Ve ), and it can also characterize tumors through dynamic changes in signal intensity (SI)


    Dynamic-enhanced (DCE) MRI can be used to grade astrocytoma as well as to identify pseudo-progressive tumors


    However, the AIF (AIF DCE DCE ) of DCE MRI is extremely susceptible to noise, which reduces the reliability of PK parameters .
    In the field of radioomics, the combination of diffusion and perfusion MRI can improve the diagnostic performance of predictive models such as survival prediction and false progression of glioblastoma .
    However, the radiomic characteristics obtained from DCE perfusion MRI vary with AIF, so the reliability is low .
    At this stage, a neural network model, the adversarial network performs well in various image conversion tasks .
    Studies have shown that the adversarial network improves the performance and stability of a number of tasks related to medical imaging .
    diagnosis

    Recently, a study published in the journal Radiology developed a deep learning model to improve the reliability of AIF in DCE MRI, and verified the reliability and diagnostic performance of PK parameters in astrocytoma grading through improved AIF.

    .

    Recently, a study published in the journal Radiology developed a deep learning model to improve the reliability of AIF in DCE MRI, and verified the reliability and diagnostic performance of PK parameters in astrocytoma grading through improved AIF.

    .


    This retrospective study included 386 patients diagnosed with astrocytoma by histopathological analysis from April 2010 to January 2018 (mean age 52 years ± 16 years [standard deviation]; 226 males) Each patient received dynamic magnetic susceptibility contrast (DSC) enhancement and DCE MRI before surgery
    .


    Obtain AIF from DSC-enhanced MRI (AIF DSC ), and measure AIF on DCE MRI (AIF DCE )


    This retrospective study included 386 patients diagnosed with astrocytoma by histopathological analysis from April 2010 to January 2018 (mean age 52 years ± 16 years [standard deviation]; 226 males) Each patient received dynamic magnetic susceptibility contrast (DSC) enhancement and DCE MRI before surgery


    In astrocytoma grading, the PK parameters derived from AIF generated DSC generated DSC and DSC have higher AUC than those derived from AIF DCE DCE (average K trans trans , 0.
    88 [95% confidence interval {CI}: 0.
    81, 0.
    93] vs 0.


     

    Table 1 The diagnostic performance of dynamic magnetic resonance enhanced pharmacokinetic parameters in distinguishing high-grade and low-grade astrocytomas
    .

    Table 1 The diagnostic performance of dynamic magnetic resonance enhanced pharmacokinetic parameters in distinguishing high-grade and low-grade astrocytomas
    .


    Figure 1 Representative K trans (left), Ve (middle) and Vp (right) derived from (A) AIF DCE , (B) AIFDSC and (C) AIF generated DSC .
    Each row represents three different AIFs, and each column represents three different PK parameter maps .
    It should be noted that the PK parameter diagram derived from AIF generated DSC (C) is  almost the same as the PK parameter diagram derived from AIF DSC (B) .
    The color bars indicate the highest and lowest values ​​of each PK parameter in this case .

    Figure 1 Representative K trans (left), Ve (middle) and Vp (right) derived from (A) AIF DCE , (B) AIFDSC and (C) AIF generated DSC .


    Each row represents three different AIFs, and each column represents three different PK parameter maps .
    It should be noted that the PK parameter diagram derived from AIF generated DSC (C) is  almost the same as the PK parameter diagram derived from AIF DSC (B) .
    The color bars indicate the highest and lowest values ​​of each PK parameter in this case .
    Figure 1 Representative K trans trans (left), Ve (middle) and Vp (right) derived from (A) AIF DCE DCE , (B) AIFDSC and (C) AIF generated DSC generated DSC .
    Each row represents three different AIFs, and each column represents three different PK parameter maps .
    It should be noted that the PK parameter diagram derived from AIF generated DSC generated DSC (C) is  almost the same as the PK parameter diagram derived from AIF DSC DSC (B) .
    The color bars indicate the highest and lowest values ​​of each PK parameter in this case.

    This research has developed a deep learning algorithm that improves the reliability and diagnostic performance of dynamic contrast-enhanced MRI pharmacokinetic parameters, and verifies the effectiveness of the algorithm as a clinical application for astrocytoma grading It provides technical support for accurately formulating treatment plans and predicting patient prognosis before clinical surgery, and opens the way for more complex related research such as predicting the false progression of glioma and gene mutations
    .

    This research has developed a deep learning algorithm that improves the reliability and diagnostic performance of dynamic contrast-enhanced MRI pharmacokinetic parameters, and verifies the effectiveness of the algorithm as a clinical application for astrocytoma grading It provides technical support for accurately formulating treatment plans and predicting patient prognosis before clinical surgery, and opens the way for more complex related research such as predicting the false progression of glioma and gene mutations
    .


    Original source:

    Original source:

    Kyu Sung Choi , Sung-Hye You , Yoseob Han , et al.


    Improving the Reliability of Pharmacokinetic Parameters at Dynamic Contrast-enhanced MRI in Astrocytomas: A Deep Learning Approach .
    DOI: 10.
    1148/radiol.
    2020192763

    Sung Choi kyu , Sung-Hye by You , Yoseob Han , et Al.
    Improving the Parameters AT.
    Pharmacokinetic The Reliability of the Dynamic Contrast-Enhanced Astrocytomas in the MRI: A Deep Learning Approach .
    The DOI: 10.
    1148 / radiol.
    2020192763 10.
    1148 / radiol.
    2020192763 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.